Uguen T, Leconte B, Desgrippes R, Tchoundeu B, François Bretagne J, Manfredi S. First description of an uterine perforation potentially imputable to treatment with bevacizumab. AO [Internet]. 2012 Nov. 1 [cited 2026 May 13];51(8):1102-4. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/31666